Tvardi Therapeutics(CH:TVRD)
CH:TVRD
Tvardi Therapeutics earnings date
Tvardi Therapeutics (TVRD) Q2 2023 Earnings Report
2 Followers
CH:TVRD Q2 2023 EPS Results
- Actual EPS
- -CHF 17.51
- Consensus EPS
- -CHF 16.25
- Beat/Miss
- Missed by -CHF 1.26
- One Year Ago EPS
- -CHF 2.42
CH:TVRD Q2 2023 Revenue Results
- Actual Revenue
- CHF 5.81M
- Expected Revenue
- CHF 5.45M
- Beat/Miss
- Beat by +CHF 367.36K
- YoY Revenue Growth
- -69.86%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/07/2023
- Time
- After Close
- Conference Call
- Monday, August 7, 2023
CH:TVRD Upcoming Earnings
Tvardi Therapeutics's next earnings date is estimated for April 6, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
CH:TVRD Q2 2023 Earnings Call
0:00 / 0:00
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:TVRD Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Apr 06, 2027 | 2026 (Q4) | -0.37- | -0.61 | ― | ― |
| Nov 13, 2026 | 2026 (Q3) | -0.48-0.40 | -0.49 | 18.64% (+0.09) | |
| Aug 14, 2026 | 2026 (Q2) | -0.59-0.58 | -0.84 | 31.00% (+0.26) | |
| May 08, 2026 | 2026 (Q1) | ―- | -2.7 | ― | |
| Mar 31, 2026 | 2025 (Q4) | -0.62-0.61 | -2.7 | 77.33% (+2.09) | |
| Nov 13, 2025 | 2025 (Q3) | -0.84-0.49 | -6.87 | 92.80% (+6.37) | |
| Aug 14, 2025 | 2025 (Q2) | -0.57-0.84 | -11.04 | 92.41% (+10.20) | |
| May 13, 2025 | 2025 (Q1) | -0.49-2.70 | -16.91 | 84.03% (+14.21) | |
| Feb 26, 2025 | 2024 (Q4) | ―-1.41 | -5.94 | 76.27% (+4.53) | |
| Nov 04, 2024 | 2024 (Q3) | -0.20-0.19 | -0.44 | 56.15% (+0.24) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

